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Gene expression profile in streptozotocin-induced diabetic In types 1 and 2 diabetes mellitus, persistent hypergly-
mice kidneys undergoing glomerulosclerosis. cemia induces progressive and irreversible glomerulo-
Background. To elucidate the molecular mechanism of dia- sclerosis, tubular atrophy, and interstitial fibrosis thatbetic nephropathy, a high-density DNA filter array was em-
ultimately results in end-stage renal failure. Data in aployed to survey the gene expression profile of streptozotocin-
large body of literature point to a number of mechanismsinduced diabetic CD-1 (ICR) mouse kidneys.
Methods. Ten-week-old CD-1 male mice were divided into that are involved in the pathogenesis of diabetic ne-
four groups: (1) control, (2) unilaterally nephrectomized (UX) phropathy. They include accumulation of nonenzymatic
mice, (3) streptozotocin (STZ)-induced diabetic (STZ) mice,
glycated end products in the kidney, oxidation of renaland (4) STZ mice with unilateral renal ablation (STZ-UX).
glycoproteins by reactive oxygen species, intracellularPathological changes were examined at 24 weeks after the
induction. The gene expression profile was compared between accumulation of sorbitol generated by the reduction of
the control and STZ mice by a Gene Discovery Array (GDA). glucose by aldose reductase, activation of the protein
Results. The glomeruli in UX mouse kidney showed promi- kinase C (PKC)-diacylglycerol pathway, and alterationsnent glomerular hypertrophy, while the accumulation of mes-
in intrarenal hemodynamics. However, a precise molecu-angial matrix was minimal. Both STZ and STZ 1 UX mice
lar basis for the evolution of renal lesions in diabeteshad significant glomerular hypertrophy and glomerulosclerosis,
and the lesions were not enhanced by renal ablation. By com- still remains unclear.
parison between control and STZ mice, 16 clones that increased In mammalian tissues, mRNA expression, related to
in expression with the induction of diabetes and 65 clones that the transcriptional activity of various genes, is in a statedecreased in diabetic kidneys were identified. The 37 known
of dynamic turnover in various developmental and patho-genes were related to glucose and lipid metabolism, ion trans-
port, transcription factors, signaling molecules, and extracellu- physiological states. In such a process, various genes are
lar matrix-related molecules. The genes known to be involved differentially up- or down-regulated depending on a given
in cell differentiation and organogenesis in various tissues (that disease process. Currently, exhaustive investigations are
is, Unc-18 homolog, POU domain transcription factor 2, lunatic
being carried out in several laboratories to isolate differ-fringe gene homolog, fibrous sheath component 1, Sox-17, fi-
entially expressed known or unknown genes in variousbulin 2, and MRJ) were found to be differentially expressed
in the early phase of diabetic kidneys. diseases. The isolation of such genes not only would lead
Conclusions. Hyperglycemia is a major determinant of glo- to the identification of candidate disease-susceptible or
merulosclerosis in STZ-induced diabetic CD-1 mice, and the resistant genes, but also would delineate novel mecha-altered gene expression in the early phase of diabetic kidney
nisms and pathways that are involved in various diseases.may be critical for the development of diabetic nephropathy.
With that knowledge, potential pharmacological or mo-
lecular therapeutic strategies targeted at various steps
of a given disease process can be ultimately developed.
To identify genes that are differentially expressed in
kidneys in a hyperglycemic state or hyperfiltration, we
previously utilized representational difference analysisKey words: CD-1 (ICR) mouse, diabetic nephropathy, hyperglycemia,
tubulointerstitial fibrosis, end-stage renal failure. of cDNA (cDNA-RDA) and identified some of the dif-
ferentially expressed genes [1, 2]. However, by this poly-Received for publication June 27, 2000
merase chain reaction (PCR)-based subtraction cloningand in revised form October 23, 2000
Accepted for publication October 26, 2000 method, that is, cDNA-RDA, it is difficult to establish
a comprehensive expression profile of various genes thatÓ 2001 by the International Society of Nephrology
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can enable one to delineate various biosynthetic or sig- phrectomized mice (UX mice), streptozotocin (STZ)-
induced diabetic mice (STZ mice), and STZ-inducednaling pathways involved in a given disease process or
to identify the interrelated genes. Such goals can be diabetic mice with unilateral nephrectomy (STZ-UX
mice). Diabetes was induced by an intraperitoneal injec-achieved only if hundreds or thousands of genes can be
simultaneously screened [3]. tion of STZ (200 mg/kg of body weight) in citrate buffer,
pH 4.6, and control and UX mice received buffer only.In view of these considerations, we employed a high-
density DNA filter array [Gene Discovery Array (GDA)] At 2 and 24 weeks after the induction of diabetes, 10
mice from each group at a given time interval were sacri-to define the transcriptional response to hyperglycemia
in the kidney. By this method, approximately 20,000 non- ficed, and their kidneys were harvested. The kidneys
were processed for morphological studies and total RNAoverlapping and nonredundant expressed sequence tag
(EST) clones are selected by bioinformatics and plotted extraction followed by hybridization with high-density
DNA filter array.on nylon filter to delineate the differential expression
by hybridizing filters with radiolabeled cDNA probes
Morphological studiesderived from control and experimental groups. At pres-
ent, the GDA is applicable only for the known human The kidneys were fixed in 10% buffered formaldehyde
and embedded in paraffin. Three-micrometer thick sec-and mouse genes and the unknown genes available as
EST mouse or human clones in the National Center for tions were stained with periodic acid silver methenamine
(PAM). The area encompassing the entire glomerulusBiotechnology Information (NCBI) database; thus, an an-
imal model of mouse with diabetes mellitus was selected. including sclerotic lesions was measured with image anal-
ysis software OPTIMAS version 6.5 (Media Cybernetics,Our choice of animal model of diabetes, the streptozo-
tocin-induced diabetic ICR mouse [1], was based upon Silver Spring, MD, USA). The cross-section yielding the
maximum diameter of the glomerulus was photographedthe following considerations. First, with this model, one
can study the genes that are relevant to the early phases and converted into a digital image, and a total of 50
glomeruli was examined from each animal. In addition,of diabetes since there is an acute onset of hyperglycemia.
Second, in current study, we revealed that the chronic ultrastructural examination of some of the glomeruli was
carried out in kidney tissues processed for electron mi-renal lesions of STZ-induced CD-1 mice show a certain
degree of mesangial expansion and sclerosis, that is, dif- croscopy as previously described [7].
fuse lesions, similar to that in human diabetic nephropa-
Analyses of gene expression profile by high-densitythy, although marked species or strain differences with
DNA arrayrespect to the severity of glomerulosclerosis are also
noted after the induction of diabetes or subtotal renal A GDA Mouse version 1.1 (Genome Systems, St. Louis,
MO, USA) was employed for comparison of the geneablation [4]. Third, the onset of hyperglycemia associated
with spontaneous type 2 diabetes mellitus of mice is expression profiles in control versus STZ mouse kidneys.
The cDNA clones spotted on Nylon filter were selectedinsidious, and one cannot negate the influence of hyper-
tension, dyslipidemia, and obesity. Moreover, the lesions by Genome Systems Inc. using bioinformatics and char-
acterized as follows: from the raw mouse EST (expressedin spontaneous models of type 2 diabetes mellitus are
distinct from human diabetic nephropathy since they sequence tag) sequences, represented in the I.M.A.G.E
libraries, the sequences of the matching vector, bacteria,are accompanied with deposition of lipids [5], immune
complexes, and amyloid in the renal glomerulus [6]. mitochondria, and ribosomal RNA, and the masking re-
gions with matching repetitive elements, and simple re-In this study, the initial experiment was directed to
the investigation of pathological alterations of glomeruli peats with the ambiguity base code (N) were removed,
and that yielded in 207,224 high-quality EST sequences.of STZ-induced diabetic ICR mice to examine the feasi-
bility of using this mouse strain for the animal model of Of these 207,224 EST clones, clusters of ESTs were gen-
erated from pairs that had at least a 95% sequence iden-diabetic nephropathy. In the second step, the changes
of gene expression profile in the early phase of diabetes, tity over a minimum 40 bp overlap. This resulted in
the grouping of 939 as known full-length clones fromthat is, the hypertrophic phase, were surveyed by high
density DNA array. the Mouse Gene Index clusters (TIGR; Institute for Ge-
nomic Research), 14,154 as clustered representative
clones and 4222 as singleton clones. These 19,315 clones,
METHODS
including full-length, clustered, and singleton clones,
Experimental design were spotted on a Nylon filter in duplicate. In addition,
32 Arbidopsis and Drosophila clones, serving as controls,Eighty 10-week-old male ICR mice, Crj: CD-1 (ICR),
were obtained from Charles River Co. (Yokohama, Ja- and 24 orientation markers were spotted.
Total RNA from whole kidney was extracted bypan) and divided into four groups, each with 20 animals,
as follows: control sham operated group, unilaterally ne- the guanidinium isothiocyanate-CsCl ultracentrifugation
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Table 1. Metabolic data after the induction of diabetes andmethod, and mRNA was isolated by oligo-(dT) cellulose
unilateral nephrectomy
chromatography using the FastTrack 2.0 Kit (Invitrogen,
Kidney BodySan Diego, CA, USA) [8–11]. The mRNA, isolated from Kidney/ Plasmaweight weight
body glucosevarious groups, was used for preparing the cDNAs by
g weight % mg/dLthe Genome Systems as follows: Approximately 2.5 mg
2 weeksof mRNA from normal or diabetic mouse kidneys were
Control 0.3460.03 36.763.9 0.9460.12 150.2625.3
used to prepare radiolabeled first-stranded cDNA by UX 0.4560.07 36.263.1 1.2560.26 136.3624.0
TZ 0.4260.10 34.862.0 1.2160.28 555.4651.39bemploying MMLV (mouse molony leukemia virus) re-
STZ-UX 0.5460.19 35.764.0 1.5360.58 542.1646.2bverse transcriptase (Promega, Madison, Wisconsin, USA),
24 weeks
10 mmol/L dA/dG/dT mix, 103 MMLV buffer and Control 0.3960.03 50.060.8 0.7860.07 110.365.3
UX 1.5360.08a 46.062.2 3.3460.14b 105.867.9[a-33P]dCTP. As an internal control, run-off RNA cor-
STZ 0.5860.18 42.066.7a 1.3660.25 454.06196.2bresponding to the Arbidopsis and Drosophila internal STZ-UX 0.8160.26 41.368.0a 2.0261.02 392.26205.9b
control clones was spotted on GDA filters. The labeled
Abbreviations are: UX, unilaterally nephrectomized ICR mice; STZ, strepto-
zotocin (STZ)-induced diabetic ICR mice; STZ-UX, STZ-induced diabetic ICRinternal control and cDNAs of various control and ex-
mice with unilateral nephrectomy.perimental animal groups were combined, and the total a P , 0.05 vs. control ICR mice; b P , 0.01 vs. control ICR mice
volume was adjusted to 46.5 mL by the addition of sterile
water. The unlabeled RNA was degraded by the addition
of 12.5 mL of 1 N NaOH and incubating it at 378C for
Statistical analysis10 minutes. The samples were then neutralized by the
addition of 12.5 mL Tris buffer, pH 6.8, and 10.0 mL HCl. The data are expressed as mean 6 SD, and a P value
of less than 0.05 was determined by Student t test.Degraded RNA and unincorporated nucleotides were
removed by G-50 spin column chromatography (Amer-
sham, Arlington Heights, IL, USA). A [a-33P]dCTP-
RESULTS
radiolabeled DNA orientation marker, which ensures
Metabolic and morphological studiesthe correct identification of all the spots on GDA filter,
In STZ and STZ-UX mice, sustained hyperglycemiawas also prepared with Rediprime DNA labeling system
was observed throughout the entire period of 24 weeks,(Amersham) and purified as described previously in this
and body weights were significantly reduced (Table 1).article.
The kidney weight and kidney/body weight ratio wereGene Discovery Array filters were prehybridized with
significantly increased in UX and UX-STZ mice com-15 mL of prewarmed NothrnMax Hybridization buffer
pared with the control. The UX mice had hypertrophied(Ambion, Austin, TX, USA) at 428C overnight. This
glomeruli; however, the matrix accumulation in the mes-was followed by hybridization with labeled control and
angium was minimal. In contrast, STZ and STZ-UX re-sample probes in 15 mL of NothrnMax hybridization
vealed marked glomerular hypertrophy and an increasebuffer, containing denatured salmon sperm DNA at 428C
in the mesangial matrix (Fig. 1). Some of the glomerulifor overnight. Filters were washed twice with 2 3 stan-
had undergone segmental sclerosis as well. The morpho-dard saline citrate (SSC) and 1% sodium dodecyl sulfate
metric analyses indicated that the glomerular size was(SDS) at 688C for 30 minutes each, followed by another
significantly increased in UX, STZ, and STZ-UX mice,
two washes with 0.6 3 SSC and 1% SDS at 688C. The
and the mesangial area was significantly expanded in
filters were then imaged by a phosphorimager (Molecu- STZ and STZ-UX mice (Fig. 2). The unilateral renal
lar Dynamics, Sunnyvale, CA, USA) set at a resolution ablation did not contribute to any significant increase in
of 100 microns in a monochromatic mode, and the data the glomerular volume or mesangial expansion in STZ
were analyzed with Genome Discovery Software (Ge- mice. Ultrastructural examination did not reveal the
nome Systems). The density values of neighboring pixels presence of any electron dense or amyloid and lipid
surrounding each four by four-primary square were used deposits in the glomeruli of STZ mice kidneys. However,
as background density. The density data were subtracted expanded mesangial area with some reduction in the
from background density. capillary filtration surfaces were observed (Fig. 3).
Clone identification Gene expression profile in normal mouse kidneys
The Unigene ID and gene name for each EST clone The GDA filters hybridized with radiolabeled control
were searched via the updated database at UniGene Mouse and STZ mouse kidney cDNAs are shown in Figure 4.
Sequence Collection at http://www.ncbi.nlm.nih.gov/ Although the background hybridization signals were
UniGene/Mm.Home.html (National Library of Medi- similar in both normal and STZ filters, a certain “bloom-
ing” action of positive hybridization signals into adjacentcine; NCBI).
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Fig. 1. Light micrographs of glomeruli of ICR mice kidney. The glo-
meruli in unilaterally nephrectomized mouse (UX) show prominent
glomerular hypertrophy and minimal accumulation of mesangial matrix.
In contrast, streptozotocin (STZ)-induced diabetic ICR mouse (STZ)
and STZ mouse with unilateral nephrectomy (STZ-UX) reveal signifi-
cant glomerular hypertrophy, a marked increase in the mesangial matrix.
(PAM, periodic acid silver methenamine stain; bar 5 50 mm).
Fig. 3. Low (A) and high (B) magnification electron micrographs of
the glomerulus from STZ-induced diabetic mouse. An expansion of the
mesangial matrix and the narrowing of capillary lumens, similar to
human diabetic nephropathy, is observed. (A, bar 5 50 mm; B, bar 5
20 mm).
neys, respectively. The top 50 highly expressed genes in
normal kidney are indicated in Table 3. Kidney andro-
gen-regulated protein was ranked at the top, and appar-
ently, it is the most abundant transcript in mouse proxi-
Fig. 2. Morphometric analyzes of glomeruli of mice kidney. Area of the
mal tubules [12]. By searching the UniGene database,glomerulus and mesangium are measured with image analysis software
OPTIMAS version 6.5. The glomerular size is increased in UX, STZ, 50 genes were classified under three categories as follows:
and STZ-UX mice, while mesangial matrix only in STZ and STZ-UX known mouse genes (N 5 25), orthologs corresponding
mice compared with the controls. Abbreviations are: CON, control
to rat and/or human known genes (N 5 8), and unknownICR mice; UX, unilaterally nephrectomized mice; STZ, streptozotocin
(STZ)-induced diabetic mice; STZ-UX, STZ-induced diabetic mice with single EST or clustered ESTs (N 5 17). The latter cate-
UX. gory indicates that approximately one third of the abun-
dantly expressed transcripts were novel genes.
Comparison of gene expression profiles betweenwells was observed. Using Genome Discovery Software,
normal versus diabetic kidneysEST clones were selected by their average intensity of
Since detection of less abundantly expressed genestwo spots. The number of the identified clones in normal
with a lower spot intensity would be readily influencedand diabetic mouse kidneys was defined according to
by the [a-33P]dCTP hybridization background, there is avarious intensity thresholds (Table 2). By setting a mini-
good chance of isolating false positive clones that do notmal intensity threshold at 2000, approximately 1008 and
829 clones were identified in normal and diabetic kid- have any differential expression. Thus, the EST clones
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Table 2. Comparison of the renal gene expression profile between
control and streptozotocin (STZ)-induced diabetic ICR mice
Intensity thresholds
1000 2000 3000 4000 5000
Controla 2460 1008 676 502 413
STZa 1407 829 561 438 371
STZ . Controlb 60 16 5 4 3
STZ , Controlc 647 65 18 11 5
a The number of genes filtered with various minimum intensity thresholds in
control and STZ mice is shown.
b The number of up-regulated genes in STZ-induced diabetic mice with a spot-
to-spot ratio greater than five is indicated; they are also filtered with various
intensity thresholds.
c The number of down-regulated genes in STZ-induced diabetic mice with a
spot-to-spot ratio greater than five is shown; they are also filtered with various
intensity thresholds.
signaling (N 5 3), and extracellular matrix (ECM) mole-
Fig. 4. Comparison of gene expression profile of control and streptozo- cules (N 5 2), and 15 genes were related to cell differenti-tocin (STZ)-induced diabetic kidney by high-density DNA array. The
ation, proliferation, and survival (Table 4).mRNA of control and STZ mouse kidneys was extracted, radiolabeled
with [a-33P]dCTP, and hybridized with Gene Discovery Array (GDA)
Mouse version 1.1. About one sixth of the total filter area of control
(CON) and STZ-induced diabetic (STZ) kidneys is shown. In each DISCUSSION
corner, the intense hybridization spots of DNA orientation markers are
The data of this investigation suggest that in the STZ-observed. All clones are double spotted to negate the false hybridization
signals or high background. The genes with a spot to spot ratio greater induced diabetic ICR mouse kidney, hyperglycemia had
than five was selected by Genome Discovery Software. Since the the major role in the development of mesangial lesions“blooming” action of positive hybridization signals into adjacent wells
progressing to glomerulosclerosis, and unilateral renalis observed, spots of the screened genes are visually inspected.
ablation only contributed minimally to the accentuation
of the disease process. In addition, the data from the
High Density DNA Array provided a global assessment
with an average intensity of more than 2000 in normal of alterations of the gene expression in the kidney during
and/or diabetic kidneys were analyzed. Approximately the early phases of STZ-induced diabetes that preceded
1008 clones in normal and 829 clones in diabetic kidneys glomerulosclerosis, although expression profile was re-
were selected (Table 2). To ensure the specificity, any lated to not only transcriptional activities but also RNA
spot with a spot–to–spot ratio of greater than five was stability and post-transcriptional factors, which contrib-
considered as significantly and differentially expressed. uted to a certain degree of the observed difference in
In addition, spots of the screened genes were visually RNA amount. It was anticipated that individual analyses
inspected since the “blooming” action of positive hybrid- of these genes, as discussed later in this article, may
ization signals into adjacent wells was observed. Analy- enhance our understanding of the events or the processes
ses by Genome Discovery Software revealed that 16 involved in the pathogenesis of diabetic nephropathy.
clones had increased expression with the induction of
Genes relevant to glucose and lipid metabolismdiabetes and 65 clones had decreased expression in the
diabetic kidneys. According to the mouse Unigene data- Liver is the primary site of glucose production. How-
base at the NCBI, the differentially expressed genes ever, recent studies utilizing isotopic and balance tech-
could be classified into four groups: known mouse genes niques suggest that approximately 25% of the systemic
(N 5 31); orthologous genes corresponding to rat and/or glucose is produced in the kidney via gluconeogenesis
human known genes (N 5 6); homologous genes with from precursors such as lactate, glutamine, and glycerol
moderate to weak similarity to yeast, nematodes, and [13, 14]. Conceivably, the kidney is an important source
mammalian genes (N 5 5), and unknown single EST or of glucose production in STZ-induced diabetic rats [15]
clustered ESTs (N 5 39). Thus, 44 ESTs out of 81 identi- and human type 2 diabetes [14, 16]. Although enzymes
fied clones were novel genes. Finally, the genes were also related to gluconeogenesis were not found in this investi-
classified into five categories according to their biological gation, one of the genes involved in carbohydrate metab-
functions. These included those related to the biosynthe- olism, for example, glucagon receptor, was found to be
sis and degradation of lipids and amino acids (N 5 7), differentially expressed. Glucagon receptor is normally
ion transport, biosynthetic precursors and organelles expressed in liver, pancreatic b cells, kidney, and adipose
tissue [17]. Its precise biological role in most of the tissues(N 5 6), transcription and protein synthesis (N 5 8),
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Table 3. Abundantly expressed genes in control kidney of male ICR mice
GenBank ID Unigene ID Intensity Gene name
AA116857 Mm.13052 107581.55 Kidney androgen-regulated protein
AA278096 Mm.21961 54801.82 ESTs, highly similar to C7–1 protein [R. norvegicus] (93%/196)
AA172974 Mm.28050 49691.93 ESTs, highly similar to CD2 cytoplasmic domain-binding protein
[H. sapiens] (91%/164 aa)
AA445684 Mm.20418 42679.32 Solute carrier family 17 (sodium/hydrogen exchanger), member 2
AA170738 Mm.25125 36367.28 ESTs, highly similar to ribose-phosphate pyrophophokinase
[R. norvegicus] (99%/145 aa)
AA512768 Mm.5291 36269.04 Ribosomal protein S5
AA444364 Mm.19367 33746.57 ESTs, highly similar to myosin light chain 1, slow twitch muscle
B/ventricular isoform [R. norvegicus] (95%/156 aa)
AA445571 Mm.35779 33182.43 ESTs, highly similar to TFIIIC2 subunit [H. sapiens] (91%/166 aa)
AA509386 Mm.18300 32547.15 NBAT (neutral and basic amino acid transporter)
AA123180 Mm.278 32529.72 Uroguanylin
AA469579 Mm.22024 32522.29 Cortactin
AA543556 Mm.4372 31110.81 RAR-related orphan receptor g
AA124856 Mm.10154 30779.41 Testis-specific protein kinase 1
AA419867 Mm.29617 30653 ESTs, highly similar to protein phosphate inhibitor 2 [R. norvegicus]
(92%/168 aa)
AA471833 Mm.9307 29516.27 Transketolase
AA510720 Mm.5274 29356.93 Cu/Zn-superoxide dismutase
AA451352 Mm.4708 27754.28 Tyrosine-protein kinase SYK
AA289387 Mm.29768 27744.19 Pyruvate dehydrogenase kinase
AA388600 Mm.9745 27366.17 Lactate dehydrogenase 2, B chain
W33527 Mm.18517 25994.99 GTPase-activating protein GAPIII
AA416215 Mm.40186 25990.88 ESTs
AA509502 Mm.40775 25873.03 ESTs, highly similar to GDP-mannose pyrophosphorylase B
[H. sapiens] (97%/147 aa)
AA389271 NA 25703.28 EST
AA445597 NA 25595.79 EST
AA388565 NA 25463.97 EST
AA512729 Mm.3373 25407.03 Cofilin, muscle isoform
AA511391 Mm.5265 25328.92 ESTs
AA275948 Mm.37214 25269.73 Perinuclear binding protein PICK1
AA390096 Mm.2632 25216.49 Latexin
AA445523 NA 25214.85 EST
AA432762 Mm.4113 25060.15 ESTs, highly similar to mRNA-associated protein mRNP41
[H. sapiens] (97%/145 aa)
AA475488 NA 24889.7 EST
AA153676 Mm.24007 24781 ESTs
AA511719 NA 24677.37 EST
AA105569 Mm.1408 24462.59 Adrenomedullin
AA396117 Mm.3460 24421.49 CD14 antigen
AA466427 Mm.20927 24180.42 Transforming growth factor beta 1-induced transcript 4
AA518419 Mm.41272 24044.34 ESTs
AA124334 NA 23865.21 EST
AA499913 Mm.29064 23750.2 Cytochrome P450, 2d9
AA124048 NA 23710.51 EST
AA466044 Mm.41348 23640.8 ESTs
AA290108 Mm.29332 23528.61 ESTs
AA500156 Mm.18590 23476.23 Cell surface glycoprotein A15
AA546728 Mm.24156 23407.62 ESTs, weakly similar to cytohesin 2 [M. musculus] (31%/137 aa)
AA396395 NA 23226.02 EST
AA396595 Mm.14868 23069.41 Granzyme G
AA536770 Mm.39990 23047.83 ESTs
AA445222 Mm.9221 23026.03 RAB4A, member RAS oncogene family
AA288222 Mm.3182 22958.49 Interferon consensus sequence-binding protein
is unknown; however, circulatory glucagon may play a activated protein kinase (AMPK), a member of a metab-
olite-sensing protein kinase family that is regulated byrole in the regulation of intrarenal hemodynamics in type
1 diabetes mellitus in humans with subsequent effects vigorous exercise, nutrient starvation, and ischemia/hyp-
oxia. It modulates cell metabolism by phosphorylatingon the mesangial cell biology [18].
Besides carbohydrate metabolism, several enzymes re- the key enzymes, and as a result, there is a stimulation
of hepatic fatty acid oxidation and ketogenesis, inhibitionlated to lipid metabolism showed a differential expres-
sion in the STZ-induced diabetic mouse kidney. One of of cholesterol and triglyceride synthesis, lipogenesis and
adipocyte lipolysis and stimulation of skeletal musclethe enzymes with up-regulated expression was AMP-
Wada et al: Gene expression in STZ-induced diabetic mice 1369
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fatty acid oxidation and glucose uptake [19]. Since the cessing, translation, and RNA replication. An important
member of this family is RNA helicase A, which is aAMPK yeast homolog Snf1p plays a major role in adapt-
ing to glucose deprivation [20] and AMPK is induced by DEAD box protein, and unwinds both double-stranded
DNA and RNA [35], while it binds to the pre-mRNAnutrient starvation in mammalian liver, the up-regulated
expression of AMP-activated kinase in diabetic kidney [36]. Since the roles of these molecules in mRNA stability
and transport are not completely defined, the significancemay be a unique tissue-specific response. The other en-
zymes or associated proteins related to lipid metabolism, of their down-regulated expression in diabetes would be
an interesting area of future investigation.that is, a-propionyl-CoA carboxylase, LCAT-like lyso-
poholipase, and apolipoprotein A-IV, also showed a dif-
Genes relevant to various signaling moleculesferential expression. Since dyslipidemia accelerates the
progression of glomerulosclerosis in diabetic nephropa- Activation of PKC has been implicated in the patho-
genesis of diabetic nephropathy. In our study, the genesthy [21–23], it is likely that the alterations in local lipid
metabolism in the diabetic kidney may be related to the related to mitogen- and stress-activated protein kinase
(SAPK) cascades and mitogen-activated protein kinaseprogression of diabetic nephropathy.
(MAPK) pathways were also differentially expressed.
Genes relevant to protein synthesis and The expression of mitogen- and stress-activated kinase-2
transcriptional regulation (MSK2) and MAP kinase 6c was down-regulated. MSK2
contains two catalytic domains similar to MSK1 and isIn liver, adipose tissue, and muscle, the metabolic al-
terations induced by diabetes are characterized by an activated by MAPK/ERK (extracellular signal-regulated
kinase) and SAPK2/p38 kinases. In the downstreamaccentuated catabolic response and diminished anabolic
activity related to protein and glucose metabolism [24]. events, MSK plays a role in the activation of certain tran-
scription factors, for example, cAMP response element-In contrast, the anabolic response is accompanied with
an increase in RNA [25, 26] and protein synthesis and binding protein (CREB), which is induced by growth
factors, cellular stresses, and various cytokines [37].decreased protein degradation [27], which ultimately
leads to renal growth and hypertrophy. Since 40S ribo- Other elements that can modulate the activity of SAPK
and MAPK include nitric oxide (NO) [38], mechanicalsomal protein S2 and ubiquitin carboxyl-terminal hy-
drolase 7 are involved in protein synthesis and ubiquitin- strain [39], and ceramide [40, 41], all of which have been
implicated in the progression of diabetic nephropathy.mediated protein degradation [28], the increased expres-
sion of the former and decreased expression of the latter With the information that the mRNA of these kinases
is differentially expressed, further studies are necessaryin this investigation seems to reflect an anabolic response
in the diabetic kidney. These observations are in line to delineate how the alterations in SAPK and MAPK
pathways modulate the responsiveness to growth factorswith the findings reported in previous metabolic studies
[24, 25, 27]. Nevertheless, the up-regulated expression in the progression of diabetic nephropathy.
of Oct2 (octamer motif-binding transcription factor) [29]
Genes relevant to extracellularand decreased expression of BTEB-1 (GC box-binding
matrix-related moleculestranscription factor) [30], Sox-17 [31], and myc-far up-
stream element binding protein [32] suggest that high An excessive accumulation of ECM proteins, that is,
types I, III, and IV collagens, fibronectin, and lamininglucose or insulin deficiency-induced alterations in the
transcriptional regulation are of a rather complex nature. has been well-documented in diabetic nephropathy; also,
a decreased expression and sulfation of proteoglycans isOne can expect up-regulation of early response genes,
such as c-fos, c-jun, c-myc, which regulate gene transcrip- implicated in the proteinuric response in diabetic ne-
phropathy. In our experiment, the differential expressiontion and contribute to renal hypertrophy in STZ-induced
mouse. They were indeed up-regulated in the rapid phase of ECM-related molecules was detected in the hypertro-
phic phase of diabetic STZ-induced glomerulopathy. Hy-of STZ-induced diabetic rats 24 hours after the onset of
hyperglycemia and returned to baseline by 48 hours [33]. aluronic acid (HA), a glycosaminoglycan (GAG), is one
of the essential components of ECM. HA-binding pro-In our experiment, we isolated mRNA two weeks after
the induction; thus, the differential expression of these teins such as CD44, aggrecan, and versican have been
implicated in the assembly of ECM by stabilizing largeearly response genes was not observed.
The alterations in the transcriptional regulation were macromolecular aggregates. Inter-a-trypsin inhibitor is
also a newly identified HA-binding protein, and its H1further reflected in the genes related to mRNA stability
and mRNA transport. Staufen is a RNA-binding protein and H2 chains are linked in vivo and in vitro to HA. This
linkage greatly improves ECM stability [42]. Fibulin-2 isthat is localized to the endoplasmic reticulum and is
believed to play a role in targeting RNA to its site of another ECM protein expressed in glomeruli [43], and
it has multifunctional binding activities for integrin aIIbb3,translation [34]. Other affected genes were related to
RNA helicases, which regulate transcription, RNA pro- fibronectin, and nidogen [44, 45]. The findings that there
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is an altered expression of interalpha-trypsin inhibitor course expression and localization of these genes using
isolated glomeruli and cultured mesangial and tubularand fibulin-2 suggest that in addition to the known abnor-
malities in ECM in diabetic nephropathy they may also cells. To achieve this purpose, the DNA microarray may
be useful because only a minute amount of RNAs iscontribute to the evolution of diabetic lesions in the
kidney. needed. In addition, a functional link between the altered
expression of these genes and diabetic nephropathy
Genes relevant to cell differentiation, growth, should be examined, since differentially expressed genes
and survival may simply reflect the response to a hyperglycemic state
rather than molecular events in the progression of dia-As indicated in Table 4, a differential expression of
genes that modulate development, differentiation, pro- betic nephropathy.
liferation, and apoptosis was noted during the survey by
High Density Array. Interestingly, seven genes including ACKNOWLEDGMENTS
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